VAERS reports by lot

Merck HPV lot H021608: VAERS reports

91 VAERS reports list lot H021608 as a Merck HPV vaccine, received between 2013-04-08 and 2016-07-26. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
91
Reports
23%
Marked serious
0
With a death outcome
17
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological4227%
Gastrointestinal1912%
General / Systemic (non-local)1610%
Musculoskeletal1510%
Cardiac / Cardiovascular149%
Dermatological (non-injection-site)138%
Injection-site / Local reaction138%
Allergic / Anaphylactic85%
Psychiatric / Neuropsychiatric75%
Respiratory53%
Thrombotic / Hematological21%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania27
Ohio15
New Jersey7
Florida4
New York4
Maryland3
Minnesota2
New Hampshire2
Connecticut2
Illinois2
Delaware1
Georgia1

Reports by month received

2013-045
2013-052
2013-067
2013-0722
2013-0812
2013-093
2013-101
2013-123
2014-0127
2014-022
2014-031
2014-071
2014-091
2014-111
2015-061
2016-021
2016-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.